Fed. Circ. Upholds Preliminary Injunction On Biaxin XL
Echoing its earlier decision upholding a preliminary injunction in a suit over patents for Abbott Laboratories' antibacterial drug Biaxin XL, a federal appeals court ruled Tuesday that Sandoz Inc. could not...To view the full article, register now.
Already a subscriber? Click here to view full article